ARCT

Arcturus Therapeutics Holdings Inc.

37.11 USD
+0.39 (+1.06%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Arcturus Therapeutics Holdings Inc. stock is up 45.13% since 30 days ago. The next earnings date is Aug 5, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 63.64% of the previous 11 May’s closed higher than April. In the last 10 Unusual Options Trades, there were 6 CALLs, 4 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
15 Apr 18:32 17 May, 2024 25.00 CALL 295 1
29 Apr 19:39 20 Sep, 2024 30.00 PUT 160 479
29 Apr 19:45 20 Sep, 2024 35.00 PUT 110 302
13 May 14:03 21 Jun, 2024 30.00 CALL 190 300
23 May 18:54 20 Dec, 2024 30.00 PUT 50 0
28 May 15:21 19 Jul, 2024 30.00 CALL 33 15
28 May 15:22 19 Jul, 2024 30.00 CALL 57 15
28 May 15:23 19 Jul, 2024 30.00 CALL 110 15
28 May 16:35 20 Sep, 2024 30.00 CALL 63 327
28 May 19:37 20 Dec, 2024 40.00 PUT 50 0

About Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNar-CF program for cystic fibrosis lung disease. It has collaboration partnerships with Vinbiocare Biotechnology Joint Stock Company for the manufacture of COVID-19 vaccines.